New 3D imaging technique glimpses cells and tissues functioning inside the body

A new non-invasive imaging technique allows scientists to see real-time 3D images of cells and tissues under the skin of living subjects, according to results of a study published online March 18 in Scientific Reports.

While dramatic advances in biological imaging have successfully captured cells and molecules in high detail, the ability to do so in living specimens—and in real time—has remained elusive, said senior author Adam de la Zerda, PhD, and his colleagues from Stanford University.

“We’ve been trying to look into the living body and see information at the level of the single cell,” he said in a university press release. “Until now there has been no way do that.”

The technique, called "molecular imaging and characterization of tissue noninvasively at cellular resolution," or MOZART, utilizes optical coherence tomography (OCT) and a combination of injected large gold nanorods and sophisticated monitoring algorithms to produce high-definition 3D images.

The researchers used the technique to image the lymph system and blood vessels of a mouse, which they were able to see functioning in real-time.

“Collectively, these methods enable high-quality noninvasive contrast-enhanced imaging of OCT in living subjects, including detection of tumor microvasculature at twice the depth achievable with conventional OCT,” the authors wrote. “These capabilities provide a powerful platform for molecular imaging and characterization of tissue noninvasively at cellular resolution.”

Doctors could someday use MOZART to improve the detection of tumors in the skin, colon and esophagus and to detect early signs of macular degeneration and blindness.

Read the full study here.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.